Accrued Expenses and Other Liabilities

9 Months Ended

Sep. 30, 2024

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

8. Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following:

	September 30,		December 31,
	2024		2023
Accrued marketing expenses	$	1,001,439	$	1,013,497
Other expenses		203,389		313,254
Accrued preclinical and clinical trial expenses		364,460		405,792
Compensation and related benefits		595,450		332,641
Accrued manufacturing expenses		4,360		97,877
Advance payments received from customers for manufacturing materials		169,758		—
Accrued franchise tax		—		38,800
	$	2,338,856	$	2,201,861